These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37755502)

  • 1. Analysis of health concerns not addressed by REACH for low tonnage chemicals and opportunities for new approach methodology.
    Botham P; Cronin MTD; Currie R; Doe J; Funk-Weyer D; Gant TW; Leist M; Marty S; van Ravenzwaay B; Westmoreland C
    Arch Toxicol; 2023 Dec; 97(12):3075-3083. PubMed ID: 37755502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental Risk Assessment of Technical Mixtures Under the European Registration, Evaluation, Authorisation and Restriction of Chemicals-A Regulatory Perspective.
    Galert W; Hassold E
    Integr Environ Assess Manag; 2021 May; 17(3):498-506. PubMed ID: 33448633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system.
    Combes R; Barratt M; Balls M
    Altern Lab Anim; 2003; 31(1):7-19. PubMed ID: 16221040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Products toxic to reproduction used in the occupational environment: Definition, risk assessment, classification].
    Lafon D
    Gynecol Obstet Fertil; 2006 Oct; 34(10):950-4. PubMed ID: 16997605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olefins and chemical regulation in Europe: REACH.
    Penman M; Banton M; Erler S; Moore N; Semmler K
    Chem Biol Interact; 2015 Nov; 241():59-65. PubMed ID: 25861726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect thresholds and 'adequate control' of risks: The fatal flaws in the EU council's position on authorisation within REACH.
    Santillo D; Johnston P
    Environ Sci Pollut Res Int; 2006 Oct; 13(6):425-31. PubMed ID: 17120834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
    Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
    Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does REACH provide sufficient information to regulate substances toxic to reproduction?
    Eliesen GAM; Woutersen M; van Engelen J; Muller A
    Regul Toxicol Pharmacol; 2023 Sep; 143():105462. PubMed ID: 37500049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trade Union Priority List for REACH authorisation.
    Romano D; Santos T; Gadea R
    J Epidemiol Community Health; 2011 Jan; 65(1):8-13. PubMed ID: 20508006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of potential carcinogenicity of organic chemicals in synthetic turf crumb rubber.
    Perkins AN; Inayat-Hussain SH; Deziel NC; Johnson CH; Ferguson SS; Garcia-Milian R; Thompson DC; Vasiliou V
    Environ Res; 2019 Feb; 169():163-172. PubMed ID: 30458352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EU Water Framework Directive and Stockholm Convention: can we reach the targets for priority substances and persistent organic pollutants?
    Fuerhacker M
    Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S92-7. PubMed ID: 19337768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential emerging chemical risks in the food chain associated with substances registered under REACH.
    Oltmanns J; Licht O; Bohlen ML; Schwarz M; Escher SE; Silano V; MacLeod M; Noteborn HPJM; Kass GEN; Merten C
    Environ Sci Process Impacts; 2020 Jan; 22(1):105-120. PubMed ID: 31790114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity studies used in registration, evaluation, authorisation and restriction of chemicals (REACH): How accurately are they reported?
    Ingre-Khans E; Ågerstrand M; Beronius A; Rudén C
    Integr Environ Assess Manag; 2019 May; 15(3):458-469. PubMed ID: 30628164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmetic UV filters in the environment-state of the art in EU regulations, science and possible knowledge gaps.
    Pawlowski S; Luetjens LH; Preibisch A; Acker S; Petersen-Thiery M
    Int J Cosmet Sci; 2023 Oct; 45 Suppl 1():52-66. PubMed ID: 37799077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact on classifications for carcinogenicity, mutagenicity, reproductive and specific target organ toxicity after repeated exposure in the first ten years of the REACH regulation.
    Karamertzanis PG; Atlason P; Nathanail AV; Provoost J; Karhu E; Rasenberg M
    Regul Toxicol Pharmacol; 2019 Aug; 106():303-315. PubMed ID: 31085250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.